• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Albemarle Corporation

    4/17/25 9:35:33 AM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 16)


    ALBEMARLE CORPORATION

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    012653101

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    012653101


    1Names of Reporting Persons

    BlackRock, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    8,970,063.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    9,694,388.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    9,694,388.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    8.1 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    ALBEMARLE CORPORATION
    (b)Address of issuer's principal executive offices:

    4250 CONGRESS STREET, SUITE 900 CHARLOTTE NC 28209
    Item 2. 
    (a)Name of person filing:

    BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
    (b)Address or principal business office or, if none, residence:

    BlackRock, Inc., 50 Hudson Yards New York, NY 10001
    (c)Citizenship:

    See Item 4 of Cover Page
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    012653101
    Item 4.Ownership
    (a)Amount beneficially owned:

    9694388
    (b)Percent of class:

    8.1  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    8970063

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    9694388

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of ALBEMARLE CORPORATION. No one person's interest in the common stock of ALBEMARLE CORPORATION is more than five percent of the total outstanding common shares.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See Exhibit 99
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    BlackRock, Inc.
     
    Signature:Spencer Fleming
    Name/Title:Managing Director
    Date:04/17/2025
    Exhibit Information

    Exhibit 24: Power of Attorney Exhibit 99: Item 7

    Get the next $ALB alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    7/11/2025$57.00Neutral → Sell
    UBS
    2/5/2025Outperform → In-line
    Evercore ISI
    1/28/2025$96.00Hold
    Truist
    1/14/2025$112.00Buy
    Clarksons Platou
    8/5/2024$102.00 → $85.00Outperform → Neutral
    Robert W. Baird
    7/31/2024$160.00 → $83.00Buy → Hold
    Berenberg
    7/17/2024$95.00Buy → Hold
    HSBC Securities
    7/11/2024$145.00 → $100.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025

      CHARLOTTE, North Carolina, June 18, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its second quarter 2025 earnings after the NYSE closes on Wednesday, July 30, 2025. The company will hold a conference call to discuss its second quarter 2025 results on Thursday, July 31, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.al

      6/18/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Publishes 2024 Sustainability Report, Updates Efforts to Reduce Carbon Footprint, Manage Freshwater Responsibly and Support Customers' Sustainability Goals

      CHARLOTTE, N.C., June 3, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity, and health, today published its 2024 Sustainability Report. Entitled Values-Led, Purpose-Driven, the report provides an update on Albemarle's achievements in line with the company's sustainability goals.   "As a values-led organization, sustainability is foundational to how we choose to operate," said Albemarle Chairman and CEO Kent Masters. "The initiatives outlined in this report speak to our commitment to creating a more resilient world. We remain dedicated to minimizing our environmental footprint,

      6/3/25 6:55:00 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Announces 126th Consecutive Quarterly Common Stock Dividend

      CHARLOTTE, N.C., May 6, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to

      5/6/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Albemarle downgraded by UBS with a new price target

      UBS downgraded Albemarle from Neutral to Sell and set a new price target of $57.00

      7/11/25 8:09:46 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle downgraded by Evercore ISI

      Evercore ISI downgraded Albemarle from Outperform to In-line

      2/5/25 9:17:34 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Truist initiated coverage on Albemarle with a new price target

      Truist initiated coverage of Albemarle with a rating of Hold and set a new price target of $96.00

      1/28/25 7:08:44 AM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    SEC Filings

    See more
    • SEC Form 11-K filed by Albemarle Corporation

      11-K - ALBEMARLE CORP (0000915913) (Filer)

      6/26/25 4:18:33 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form SD filed by Albemarle Corporation

      SD - ALBEMARLE CORP (0000915913) (Filer)

      6/2/25 4:19:31 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - ALBEMARLE CORP (0000915913) (Filer)

      5/9/25 4:24:16 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Oconnell Diarmuid B. was granted 2,762 shares, increasing direct ownership by 50% to 8,233 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      7/3/25 3:35:31 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Director Brlas Laurie was granted 2,762 shares, increasing direct ownership by 85% to 6,003 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      7/3/25 3:34:59 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Director Obrien James J /Ky was granted 2,762 shares, increasing direct ownership by 52% to 8,085 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      7/3/25 3:34:36 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      11/7/23 4:39:49 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    See more
    • Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

      Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

      6/19/24 7:00:00 AM ET
      $ALB
      Major Chemicals
      Industrials
    • International Paper Announces Changes to Its Board of Directors

       Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

      5/23/24 10:51:00 AM ET
      $ALB
      $AVNT
      $IP
      Major Chemicals
      Industrials
      Paper
      Basic Materials
    • Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

      CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

      8/2/23 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

      SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

      12/5/24 7:27:01 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by Albemarle Corporation

      SC 13G - ALBEMARLE CORP (0000915913) (Subject)

      11/13/24 12:52:42 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

      SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

      11/13/24 10:27:59 AM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Financials

    Live finance-specific insights

    See more
    • Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025

      CHARLOTTE, North Carolina, June 18, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its second quarter 2025 earnings after the NYSE closes on Wednesday, July 30, 2025. The company will hold a conference call to discuss its second quarter 2025 results on Thursday, July 31, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.al

      6/18/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Announces 126th Consecutive Quarterly Common Stock Dividend

      CHARLOTTE, N.C., May 6, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to

      5/6/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Reports First Quarter 2025 Results

      CHARLOTTE, N.C., April 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2025. First-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.1 billion, with double-digit volume growth in Specialties (+11%) and record Energy Storage lithium salt production from the company's integrated conversion networkNet income of $41 million, o

      4/30/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials